LDL and UV-oxidized LDL induce upregulation of iNOS and NO in unstimulated J774 macrophages and HUVEC

APMIS

Volumn 117, Issue 1, 2009, Pages 1-9

  Persson, Karin ^a,b   Sauma, Lilian ^b   SÄfholm, Annette ^b   Xu, Lihua ^a   Li, Wei ^b   Yuan, Xi Ming ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Department of Medical and Health Sciences   (Sweden)

Author keywords

INOS; Low density lipoprotein; Macrophages; Nitric oxide

Indexed keywords

7 OXYSTEROL DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; IRON DERIVATIVE; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; STEROL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCUBATION TIME; MACROPHAGE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET RADIATION;

ANIMALS; CELLS, CULTURED; CHOLESTEROL, LDL; ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXIDATION-REDUCTION; PEPTIDYL-DIPEPTIDASE A; RNA, MESSENGER; ULTRAVIOLET RAYS; UMBILICAL CORD; UP-REGULATION;

EID: 58649084150     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00001.x     Document Type: Article

References (35)

1. Jessup W, Wilson P, Gaus K, Kritharides L. Oxidized lipoproteins and macrophages. Vasc Pharmacol 2002 38 : 239 48.
2. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979 76 : 333 7.
3. Ross R. Atherosclerosis - an inflammatory disease. N Eng J Med 1999 340 : 115 26.
4. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996 20 : 707 27.
5. Mangin EL, Kugiyama K, Nguy JH, Kerns SA, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium dependent relaxation of rabbit aorta. Circ Res 1993 72 : 161 6.
6. Kugiyama K, Kerns SA, Morrisett JD, Robert R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990 344 : 160 2.
7. Hein TW, Liao JC, Kuo L. OxLDL specifically impairs endothelium dependent, NO-mediated dilation of coronary arterioles. Am J Physiol Heart Circ Physiol 2000 278 : H175 83.
8. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981 1 : 1293 4.
9. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992 86 : 803 11.
10. Yuan XM, Li W. The iron hypothesis of atherosclerosis and its clinical impact. Ann Med 2003 35 : 578 91.
11. Minqin R, Watt F, Huat BT, Halliwell B. Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. Free Radic Biol Med 2003 15 : 746 52.
12. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivates. J Biol Chem 1994 269 : 26066 75.
13. Patel RP, Levonen A, Crawford JH, Darley-Usmar VM. Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis. Cardiovasc Res 2000 47 : 465 74.
14. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001 357 : 593 615.
15. Weiss G, Werner-Felmayer G, Werner ER, Grunewald K, Wachter H, Hentze MW. Iron regulates nitric oxide synthase activity by controlling nuclear Transcription. J Exp Med 1994 180 : 969 76.
16. Bolton EJ, Jessup W, Stanley KK, Dean RT. Enhanced LDL oxidation by murine macrophage foam cells and their failure to secrete nitric oxide. Atherosclerosis 1994 106 : 213 23.
17. Mohan PF, Desaiah D. Very low density and low density lipoproteins induce nitric oxide synthesis in macrophages. Biochem Biophys Res Commun 1994 204 : 1047 54.
18. Yang X, Cai B, Sciacca RR, Cannon PJ. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circ Res 1994 74 : 318 28.
19. Thai SF, Lewis JG, Willliams RB, Johnson SP, Adams DO. Effects of oxidized LDL on mononuclear phagocytes: inhibition of induction of four inflammatory cytokine gene RNAs, release of NO, and cytolysis of tumor cells. J Leukoc Biol 1995 57 : 427 33.
20. Matthys KE, Van Hove CE, Jorens PG, Rosseneu M, Marescau B, Herman AG, et al. Dual effects of oxidized low-density lipoprotein on immune stimulated nitric oxide and prostaglandin release in macrophages. Eur J Pharmacol 1996 298 : 97 103.
21. Matsuno R, Aramaki Y, Arima H, Tsuchiya S. Scavenger receptors may regulate nitric oxide production from macrophages stimulated by LPS. Biochem Biophys Res Commun 1997 237 : 601 5.
22. Liu SX, Chen Y, Zhou M, Wan J. Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages. Atherosclerosis 1998 136 : 43 9.
23. Huang A, Li C, Kao RL, Stone WL. Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages. Free Radic Biol Med 1999 26 : 526 37.
24. Grankvist K, Lernmark A, Taljedal IB. Trypan blue as a marker of plasma membrane permeabililty in alloxan-treated mouse islet cells. J Endocrinol Invest 1979 2 : 139 45.
25. Yuan XM, Li W, Olsson AG, Brunk U. The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage. Atherosclerosis 1997 133 : 153 61.
26. Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc Natl Acad USA 2001 98 : 12814 9.
27. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums MH, et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996 75 : 77 85.
28. Luoma JS, Yla-Herttuala S. Expression of inducible nitric oxide synthase in macrophages and smooth muscle cells in various types of human atherosclerotic lesions. Virchows Arch 1999 434 : 561 8.
29. Diet F, Pratt RE, Berry GJ, Momose N, GH Gibbons, Dzau VJ. Circulation 1996 94 : 2756 67.
30. Persson K, Whiss PA, Nyhlén K, Jacobsson-Strier M, Glindell M, Andersson RGG. NO donors and ACE inhibitors act in concert to inhibit human ACE activity and platelet aggregation in vitro. Eur J Pharmacol 2000 406 : 15 23.
31. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJR, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J Biol Chem 1997 272 : 4959 63.
32. Baoutina A, Dean RT, Jessup W. Trans-plasma membrane electron transport induces macrophage-mediated low density lipoprotein oxidation. FASEB J 2001 15 : 1580 2.
33. Van Reyk DM, Jessup W, Dean RT. Prooxidant and antioxidant activities of macrophages in metal-mediated LDL oxidation: the importance of metal sequestration. Arterioscler Thromb Vasc Biol 1999 19 : 1119 24.
34. Kolodgie FD, Gold HK, Burke AP. Intraplaque hemorrhage and progression of coronary atheroma. N Eng J Med 2004 349 : 2316 25.
35. Yuan XM, Li W, Olsson AG, Brunk UT. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis 1996 124 : 61 73.